AU2003203801A1 - Pharmaceutically active compounds and methods of use - Google Patents

Pharmaceutically active compounds and methods of use

Info

Publication number
AU2003203801A1
AU2003203801A1 AU2003203801A AU2003203801A AU2003203801A1 AU 2003203801 A1 AU2003203801 A1 AU 2003203801A1 AU 2003203801 A AU2003203801 A AU 2003203801A AU 2003203801 A AU2003203801 A AU 2003203801A AU 2003203801 A1 AU2003203801 A1 AU 2003203801A1
Authority
AU
Australia
Prior art keywords
methods
active compounds
pharmaceutically active
pharmaceutically
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003203801A
Other versions
AU2003203801B8 (en
AU2003203801B2 (en
Inventor
Graham J. Durant
Seetharamaiyer Padmanabhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scion Pharmaceuticals Inc
Original Assignee
Scion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1998/022309 external-priority patent/WO1999020599A1/en
Application filed by Scion Pharmaceuticals Inc filed Critical Scion Pharmaceuticals Inc
Priority to AU2003203801A priority Critical patent/AU2003203801B8/en
Priority claimed from AU2003203801A external-priority patent/AU2003203801B8/en
Publication of AU2003203801A1 publication Critical patent/AU2003203801A1/en
Assigned to SCION PHARMACEUTICALS, INC. reassignment SCION PHARMACEUTICALS, INC. Request for Assignment Assignors: CAMBRIDGE NEUROSCIENCE, INC.
Application granted granted Critical
Publication of AU2003203801B2 publication Critical patent/AU2003203801B2/en
Publication of AU2003203801B8 publication Critical patent/AU2003203801B8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003203801A 1997-10-21 2003-04-24 Pharmaceutically active compounds and methods of use Ceased AU2003203801B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003203801A AU2003203801B8 (en) 1997-10-21 2003-04-24 Pharmaceutically active compounds and methods of use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60064830 1997-10-21
PCT/US1998/022309 WO1999020599A1 (en) 1997-10-21 1998-10-20 Pharmaceutically active compounds and methods of use
AU13626/99A AU1362699A (en) 1997-10-21 1998-10-20 Pharmaceutically active compounds and methods of use
AU2003203801A AU2003203801B8 (en) 1997-10-21 2003-04-24 Pharmaceutically active compounds and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU13626/99A Division AU1362699A (en) 1997-10-21 1998-10-20 Pharmaceutically active compounds and methods of use

Publications (3)

Publication Number Publication Date
AU2003203801A1 true AU2003203801A1 (en) 2003-06-12
AU2003203801B2 AU2003203801B2 (en) 2006-06-29
AU2003203801B8 AU2003203801B8 (en) 2006-07-06

Family

ID=39338624

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003203801A Ceased AU2003203801B8 (en) 1997-10-21 2003-04-24 Pharmaceutically active compounds and methods of use

Country Status (1)

Country Link
AU (1) AU2003203801B8 (en)

Similar Documents

Publication Publication Date Title
AU2466099A (en) Pharmaceutically active compounds and methods of use thereof
IL127559A0 (en) Compounds and methods for providing pharmacologically active preparations and uses thereof
AU4477597A (en) New pharmaceutically active compounds
AU7224396A (en) Pharmaceutically active quinazoline compounds
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU6555198A (en) Implanted structures and methods of formation
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
EP1115396A4 (en) Pharmaceutically active compounds and methods of use thereof
AU6406299A (en) Methods and apparatus for improved administration of pharmaceutically active compounds
PL315635A1 (en) Method of solubilising hardly pharmaceutically active substances
AU8166098A (en) Removal of biologically active agents
AU1616499A (en) Chemokine variants and methods of use
AU3068699A (en) Skin equivalent and methods of forming and using same
AU3656397A (en) Formulations of vesicant drugs and methods of use thereof
EP1154997A4 (en) Pharmaceutically active compounds and methods of use thereof
AU2080199A (en) New pharmaceutically active compounds
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU1969800A (en) Combination of active agents
AU2036297A (en) Topical formulations of aciclovir
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU7378498A (en) Hybrid ribozymes and methods of use
AU3118297A (en) Sok-1 and methods of use
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU2662799A (en) Modified pharmacologically active agents and improved therapeutic methods employing same
AU6412599A (en) Oxybutynin formulations and methods of use